1. Home
  2. MDGL vs CVLT Comparison

MDGL vs CVLT Comparison

Compare MDGL & CVLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • CVLT
  • Stock Information
  • Founded
  • MDGL 2011
  • CVLT 1996
  • Country
  • MDGL United States
  • CVLT United States
  • Employees
  • MDGL N/A
  • CVLT N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • CVLT Computer Software: Prepackaged Software
  • Sector
  • MDGL Health Care
  • CVLT Technology
  • Exchange
  • MDGL Nasdaq
  • CVLT Nasdaq
  • Market Cap
  • MDGL 6.8B
  • CVLT 6.8B
  • IPO Year
  • MDGL N/A
  • CVLT 2006
  • Fundamental
  • Price
  • MDGL $290.96
  • CVLT $178.04
  • Analyst Decision
  • MDGL Strong Buy
  • CVLT Buy
  • Analyst Count
  • MDGL 10
  • CVLT 10
  • Target Price
  • MDGL $420.63
  • CVLT $182.75
  • AVG Volume (30 Days)
  • MDGL 361.7K
  • CVLT 498.7K
  • Earning Date
  • MDGL 05-01-2025
  • CVLT 04-29-2025
  • Dividend Yield
  • MDGL N/A
  • CVLT N/A
  • EPS Growth
  • MDGL N/A
  • CVLT N/A
  • EPS
  • MDGL N/A
  • CVLT 1.68
  • Revenue
  • MDGL $317,383,000.00
  • CVLT $995,619,000.00
  • Revenue This Year
  • MDGL $264.55
  • CVLT $15.91
  • Revenue Next Year
  • MDGL $67.21
  • CVLT $11.79
  • P/E Ratio
  • MDGL N/A
  • CVLT $108.36
  • Revenue Growth
  • MDGL N/A
  • CVLT 18.63
  • 52 Week Low
  • MDGL $200.08
  • CVLT $105.76
  • 52 Week High
  • MDGL $377.46
  • CVLT $190.11
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 40.85
  • CVLT 59.98
  • Support Level
  • MDGL $280.00
  • CVLT $169.38
  • Resistance Level
  • MDGL $307.54
  • CVLT $182.85
  • Average True Range (ATR)
  • MDGL 15.97
  • CVLT 6.34
  • MACD
  • MDGL -2.00
  • CVLT 1.05
  • Stochastic Oscillator
  • MDGL 15.88
  • CVLT 76.93

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About CVLT Commvault Systems Inc.

CommVault Systems Inc provides data and information management software applications and services. The firm sells software licenses and services to large global enterprises, small- and midsize businesses, and government agencies through both its salesforce and its network of reseller partners. Its software solutions include Commvault Complete Backup and Recovery, HyperScale, Hedvig, and Metallic. The company operates in the United States and exports to many other countries.

Share on Social Networks: